Brief: Annexin Pharmaceuticals Q2 Loss SEK 14.5 Mln
July 18 (Reuters) - Annexin Pharmaceuticals AB (publ)
ANNX.ST :
* Q2 LOSS FOR PERIOD SEK 14.5 MILLION VERSUS LOSS SEK 8.6
MILLION
YEAR AGO
* Q2 OPERATING LOSS SEK 14.5 MILLION VERSUS LOSS SEK 8.6
MILLION
YEAR AGO
Source text for Eikon: ID:nMFN3vlJP6
Further company coverage: ANNX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed